Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan vs Lercanidipine in Hypertensive HIV Patients
NCT00564057Phase 4Unknown
- Sponsor
- University of Insubria
- Start
- Sep 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of candesartan in hypertension (HTN) (2 arms), sponsored by University of Insubria. Primary endpoints: Morpho-functional left ventricle characteristics at 1 year and Metabolic profile at 1 year. Status: unknown.
02
Drugs
candesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00564057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564057.